[PDF] Top 20 Demanda Laboral Por Despido Injustificado

... Our patient had had chronic kidney disease since 2010, with rapid worsening of renal function in the last 6 mo. Bone marrow aspirate confirmed MGUS. The renal biopsy showed C3-GMN and the skin biopsy ... See full document

... which monoclonal immuno- globulins form crystals and their different locations in various cells have not been elucidated ...the monoclonal κ light chain that result in substitution of polar residues by ... See full document

... A case of MPGN resulting from multiple myeloma- induced monoclonal gammopathy was recently reported ...[9]. Monoclonal gammopathy of renal significance (MGRS) is a ... See full document

... A 57-year-old Caucasian woman with a four-year history of monoclonal gammopathy of undetermined significance (MGUS) complained of several weeks of dry mouth, polydipsia and episodes of confusion. Her ... See full document

... had renal lesions associated with IgM- secreting monoclonal proliferations but did not fulfill the criteria for having Waldenström’s macroglobuline- ...of renal lesions occurring in patients ... See full document

... in case of a small clone, but it may be advantageous for patients with a poor performance status due to the MGUS-associated disorder, and in case with a significant plasma cell clone (M-protein ≥10 ... See full document

... An 81-year-old female patient, Mrs. NM, presented to casualty with a 3-year history of melaena, haematemesis and lethargy. Previous medical history recorded 8 un- eventful deliveries and multiple tooth extractions which ... See full document

... review; monoclonal antibodies are produced by expanded single B-cell clones and are var- iously known as monoclonal protein, M protein, M com- ponent, monoclonal gammopathy, or ...class. ... See full document

... The prognosis of PGNMID is poor, during a mean fol- low up of 30.3 months, 21.9% patients progressed to ESRD, and 37.5% had persistent renal dysfunction. Only 3.7% M-spike negative patient at presentation ... See full document

... serum C3 level, haematuria and nephrotic syndrome, and experienced rapid worsening of renal function over a period of 10 ...a monoclonal IgG λ ...of C3 glomerulonephritis, with ... See full document

... Potentiating cytotoxicity and overcoming drug resistance. DCA was found in many studies to potentiate the effect of cytotoxic drugs or radiation therapy on cancer cells. The combination of DCA and arsenic trioxide ... See full document

... businessman with no family history or occupational risk factor. He had a normal haematological and biochemical profile. ESR was normal at 5 mm/hr. Total serum pro- tein was elevated at 89.27 g/L (range 60-85 g/L) and al- ... See full document

... current case, nivolumab was perman- ently discontinued and the patient continued on a lengthy tapering course of steroids for approximately 4 ...a case of a melanoma patient who experienced continued tumor ... See full document

... [10] Perez-Persona E, Vidriales MB, Mateo G, Garcia-Sanz R, Mateos MV, de Coca AG, Galende J, Martin-Nunez G, Alonso JM, de Las Heras N, Hernandez JM, Martin A, Lopez- Berges C, Orfao A and San Miguel JF. New cri- teria ... See full document

... Other pathogenic events. Secondary Ig translocations, including most IgK and IgL translocations and IgH translocations not involv- ing one of the seven primary partners, can occur at all stages of dis- ease, and with a ... See full document

... Introduction Population-based studies have shown that fracture risk is increased in MGUS.1,2 Previously,3 we used high-resolution peripheral quantitative computed tomography HRpQCT imagi[r] ... See full document

... Most human cancers are preceded by a long phase of premalignant lesions that are more common than the cancer itself. Multiple myeloma (MM) is a common hematologic malignancy wherein tumor cells grow predominantly in the ... See full document

... undetermined significance (MGUS) or smoldering myeloma, less frequently with symptomatic multiple mye- loma ...events associated with cardiac AL-amyloidosis were reported ... See full document

... Our results have also clinical implications. RHuEpo and Epo-stimulating agents (ESA), used to treat or to prevent anemia in oncological patients receiving chemotherapy including MM patients, negatively affected patient ... See full document

... At registration of MGUS in the DNPR, the median age of the 327 patients was 71.0 years (range 34.6–91.7 years), and 166 (51%) were men. In 219 patients, the diagnosis was registered at the two university hospitals, in 87 ... See full document